Cargando…

Efficacy and safety of particle therapy for inoperable stage II-III non-small cell lung cancer: a systematic review and meta-analysis

BACKGROUND AND PURPOSE: Particle therapy, mainly including carbon-ion radiotherapy (CIRT) and proton beam therapy (PBT), has dose distribution advantages compared to photon radiotherapy. It has been widely reported as a promising treatment method for early non-small cell lung cancer (NSCLC). However...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yanliang, Luo, Hongtao, Liu, Ruifeng, Tan, Mingyu, Wang, Qian, Wu, Xun, Du, Tianqi, Liu, Zhiqiang, Sun, Shilong, Zhang, Qiuning, Wang, Xiaohu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201735/ https://www.ncbi.nlm.nih.gov/pubmed/37217970 http://dx.doi.org/10.1186/s13014-023-02264-x

Ejemplares similares

Does particle radiation have superior radiobiological advantages for prostate cancer cells? A systematic review of in vitro studies
por: Du, Tian-Qi, et al.
Publicado: (2022)

EZH2 as a Prognostic Factor and Its Immune Implication with Molecular Characterization in Prostate Cancer: An Integrated Multi-Omics in Silico Analysis
por: Du, Tian-Qi, et al.
Publicado: (2022)

Bevacizumab is an effective treatment for symptomatic cerebral necrosis after carbon ion therapy for recurrent intracranial malignant tumours: A case report
por: Liu, Ruifeng, et al.
Publicado: (2022)

Charged Particle Irradiation for Pancreatic Cancer: A Systematic Review of In Vitro Studies
por: Wang, Dandan, et al.
Publicado: (2022)

Adjuvant Radiotherapy of Involved Field versus Elective Lymph Node in Patients with Operable Esophageal Squamous Cell Cancer: A Single Institution Prospective Randomized Controlled Study
por: Liu, Ruifeng, et al.
Publicado: (2021)

LIF Inhibits Proliferation of Esophageal Squamous Carcinoma Cells by Radiation Mediated Through JAK-STAT Signaling Pathway
por: Luo, Hongtao, et al.
Publicado: (2023)

Stereotactic body radiation therapy or surgery for stage I–II non-small cell lung cancer treatment?—outcomes of a meta-analysis
por: Zhang, Qiuning, et al.
Publicado: (2019)

Charged particle therapy for high-grade gliomas in adults: a systematic review
por: Wang, Yuhang, et al.
Publicado: (2023)

Efficacy and safety of carbon ion radiotherapy for chordomas: a systematic review and meta-analysis
por: Dong, Meng, et al.
Publicado: (2023)

Efficacy and safety of carbon ion radiotherapy for bone sarcomas: a systematic review and meta-analysis
por: Dong, Meng, et al.
Publicado: (2022)

A pancancer analysis of the carcinogenic role of receptor-interacting serine/threonine protein kinase-2 (RIPK2) in human tumours
por: Zhang, Hanqun, et al.
Publicado: (2022)

Efficacy and safety of proton beam therapy for rhabdomyosarcoma: a systematic review and meta-analysis
por: Dong, Meng, et al.
Publicado: (2023)

Review of possible mechanisms of radiotherapy resistance in cervical cancer
por: Zhang, Hanqun, et al.
Publicado: (2023)

Results of systemic treatment of cutaneous melanoma in inoperable stage III and IV
por: Cybulska-Stopa, Bożena, et al.
Publicado: (2013)

Efficacy and safety of carbon‐ion radiotherapy for the malignant melanoma: A systematic review
por: Li, Chengcheng, et al.
Publicado: (2020)

Safety and Efficacy of PD‐1/PD‐L1 inhibitors combined with radiotherapy in patients with non‐small‐cell lung cancer: a systematic review and meta‐analysis
por: Geng, Yichao, et al.
Publicado: (2021)

Immunotherapy in inoperable stage III non-small cell lung cancer: a review
por: Jain, Natasha A, et al.
Publicado: (2019)

Analysis of the efficacy and safety of iodine-125 seeds implantation in the treatment of patients with inoperable early-stage non-small cell lung cancer
por: Chen, Enli, et al.
Publicado: (2021)

Epidermal growth factor receptor tyrosine kinase inhibitors combined with thoracic radiotherapy or chemoradiotherapy for advanced or metastatic non-small cell lung cancer: A systematic review and meta-analysis of single-arm trials
por: Liu, Ruifeng, et al.
Publicado: (2019)

Therapeutic revolution for inoperable stage III non-small cell lung cancer in the immune era
por: Li, Jiakang, et al.
Publicado: (2022)

Late-course accelerated Hyperfractionation vs. Conventional Fraction Radiotherapy under precise technology plus Concurrent Chemotherapy for Esophageal Squamous Cell Carcinoma: comparison of efficacy and side effects
por: Luo, Hongtao, et al.
Publicado: (2020)

Effect of Carbon Ion Radiation Induces Bystander Effect on Metastasis of A549 Cells and Metabonomic Correlation Analysis
por: Yang, Zhen, et al.
Publicado: (2021)

Carbon Ion Therapy Inhibits Esophageal Squamous Cell Carcinoma Metastasis by Upregulating STAT3 Through the JAK2/STAT3 Signaling Pathway
por: Luo, Hongtao, et al.
Publicado: (2020)

Corrigendum: Effect of Carbon Ion Radiation Induce Bystander Effect on Metastasis of A549 Cells and Metabonomic Correlation Analysis
por: Yang, Zhen, et al.
Publicado: (2021)

Can LMWH improve the outcome of patients with inoperable stage III non-small cell lung cancer?
por: Kucukoner, Mehmet, et al.
Publicado: (2012)

Preliminary study on radiosensitivity to carbon ions in human breast cancer
por: Zhang, Qiuning, et al.
Publicado: (2020)

Surgical perspective in neoadjuvant chemoimmunotherapy for stage II–III non‐small cell lung cancer
por: Hong, Tao, et al.
Publicado: (2021)

Combined Radiomics–Clinical Model to Predict Radiotherapy Response in Inoperable Stage III and IV Non-Small-Cell Lung Cancer
por: Chen, Wenrui, et al.
Publicado: (2022)

Inoperable or incompletely resected craniofacial osteosarcoma treated by particle radiotherapy
por: Seidensaal, Katharina, et al.
Publicado: (2022)

Silencing of the lncRNA H19 enhances sensitivity to X-ray and carbon-ions through the miR-130a-3p /WNK3 signaling axis in NSCLC cells
por: Zhao, Xueshan, et al.
Publicado: (2021)

A phase I study of nedaplatin, pemetrexed and thoracic intensity-modulated radiotherapy for inoperable stage III lung adenocarcinoma
por: Lu, Yiyu, et al.
Publicado: (2016)

Pattern-of-failure and salvage treatment analysis after chemoradiotherapy for inoperable stage III non-small cell lung cancer
por: Taugner, Julian, et al.
Publicado: (2020)

Differential role of residual metabolic tumor volume in inoperable stage III NSCLC after chemoradiotherapy ± immune checkpoint inhibition
por: Unterrainer, Marcus, et al.
Publicado: (2021)

A phase II open-label multicenter study of gefitinib in combination with irradiation followed by chemotherapy in patients with inoperable stage III non-small cell lung cancer
por: Levy, Antonin, et al.
Publicado: (2016)

Randomized phase II trial of S‐1 plus cisplatin or docetaxel plus cisplatin with concurrent thoracic radiotherapy for inoperable stage III non‐small cell lung cancer
por: Shimokawa, Tsuneo, et al.
Publicado: (2020)

Inoperable Cancer
Publicado: (1901)

Integrating radiosensitive genes improves prediction of radiosensitivity or radioresistance in patients with oesophageal cancer
por: Zhang, Qiuning, et al.
Publicado: (2019)

A phase II study of concurrent chemoradiotherapy and erlotinib for inoperable esophageal squamous cell carcinoma
por: Zhao, Chuanhua, et al.
Publicado: (2016)

Clinical Management and Outcome of Grade III Pneumonitis after Chemoradioimmunotherapy for Inoperable Stage III Non-Small Cell Lung Cancer—A Prospective Longitudinal Assessment
por: Kauffmann-Guerrero, Diego, et al.
Publicado: (2021)

Hypofractionated radiotherapy for medically inoperable stage I non‐small cell lung cancer
por: Jiang, Wei, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_dg8m30vrbnojq4mc06g8no4g4t